Mahjoub M A, Iman M, Salimi-Sabour E, Anbara H
Department of Pharmaceutics, Faculty of Pharmacy, Baqiyatallah University of Medical Sciences, Tehran, Iran.
Department of Pharmacognosy and Traditional Pharmacy, Faculty of Pharmacy, Baqiyatallah University of Medical Sciences, Tehran, Iran.
Arch Razi Inst. 2024 Dec 31;79(6):1271-1280. doi: 10.32592/ARI.2024.79.6.1271. eCollection 2024 Dec.
The objective of this study was to assess the anti-inflammatory effects of a chitosan (CHT) film loaded with an extract, both in vitro and in vivo. contains shikonin (SHKN), a naphthoquinone that exhibits notable anti-inflammatory, antimicrobial, and wound-healing properties. A high-quality SHKN extract was standardised and incorporated into CHT films, which were then evaluated in terms of their stability, drug release, antibacterial effectiveness and anti-inflammatory activity. Two concentrations of SHKN were employed the preparation of CHT films. studies showed that the optimal CHT film formulation remained stable for a period of four weeks at 4°C. A biphasic SHKN release profile was observed from the films, indicative of a sustained drug release mechanism. The films exhibited a strong antibacterial effect against Staphylococcus aureus (S. aureus) due to the presence of SHKN, but no such effect against Escherichia coli (E. coli). Furthermore, a synergistic antibacterial effect was noted when CHT was combined with extract against S. aureus. In vivo, the CHT film with A. euchroma extract demonstrated anti-inflammatory effects in a mice paw swelling test, comparable to betamethasone. The mice were divided into four groups of six, and the difference was not statistically significant (p-value>0.05). Histological examination substantiated the reduction of immune cell infiltration in the treatment group. The study concluded that CHT films containing A. euchroma extract exhibit promising anti-inflammatory and antimicrobial properties. Furthermore, they are suitable for use as wound dressings, offering high portability, mechanical strength, and non-adhesive properties, which makes them suitable for use in a variety of medical and pharmaceutical applications, as well as potential carriers for antimicrobial agents and antioxidants in various industries. In conclusion, the utilisation of chitosan films embedded with extract may provide an accessible and convenient therapeutic application for a range of wounds and inflammatory conditions.
本研究的目的是在体外和体内评估负载提取物的壳聚糖(CHT)薄膜的抗炎作用。该提取物含有紫草素(SHKN),一种具有显著抗炎、抗菌和伤口愈合特性的萘醌。对高质量的SHKN提取物进行标准化处理并将其掺入CHT薄膜中,然后对其稳定性、药物释放、抗菌效果和抗炎活性进行评估。制备CHT薄膜时采用了两种浓度的SHKN。研究表明,最佳的CHT薄膜配方在4°C下可保持四周稳定。从薄膜中观察到双相的SHKN释放曲线,表明存在持续的药物释放机制。由于SHKN的存在,这些薄膜对金黄色葡萄球菌(S. aureus)表现出强大的抗菌作用,但对大肠杆菌(E. coli)没有这种作用。此外,当CHT与提取物联合使用时,对金黄色葡萄球菌具有协同抗菌作用。在体内,含有新疆紫草提取物的CHT薄膜在小鼠足肿胀试验中显示出抗炎作用,与倍他米松相当。将小鼠分为四组,每组六只,差异无统计学意义(p值>0.05)。组织学检查证实治疗组免疫细胞浸润减少。该研究得出结论,含有新疆紫草提取物的CHT薄膜具有良好的抗炎和抗菌特性。此外,它们适合用作伤口敷料,具有高便携性、机械强度和非粘性,这使其适用于各种医疗和制药应用,以及各种行业中抗菌剂和抗氧化剂的潜在载体。总之,嵌入提取物的壳聚糖薄膜的利用可能为一系列伤口和炎症性疾病提供一种便捷的治疗应用。